|
ACADEMIC YEAR 2010-2011 |
The American Parkinson Disease Association Inc. has not budgeted research funds to be awarded during the 2010-2011 and following academic years. |
|
The American Parkinson Disease Association will be accepting new applications for the Medical Student Summer Fellowships for 2010. Applications are to be submitted electronically by January 31, 2010. The American Parkinson Disease Association will not be accepting applications for Research Grants, Postdoctoral Fellowships, the Cotzias Memorial Fellowships, the Roger Duvoisin Research Grant and Centers for Advanced Research for fiscal year 2010-2011. You may contact Michele Popadynec, RN, MPS at 800 223-2732 ext. 118 or via email at www.mpopadynec@apdaparkinson.org for more information. |
Medical Students Summer Fellowships |
The APDA Summer Fellowships are designed to provide a stipend to enable medical students to perform supervised laboratory or clinical research designed to clarify our understanding of Parkinson’s disease, its nature, manifestations, etiology or treatment. It is hoped this experience will stimulate a student’s interest in future research in the field of Parkinson’s disease and related disorders.This is a Fellowship of $4,000 for a three(3) month summer commitment. |
DeadLine | 1/31/2010 Details |
Fellowship/Research Grant Application |
|
APDA Research Funding Fiscal Year 2008 - 2009 |
|
George C. Cotzias, MD Memorial Fellowships |
Talene Yacoubian, MD, Ph.D.
The University of Alabama
Birmingham, Al | Role of 14-3-3 Proteins in Alpha Synuclein Induced Neurotoxicity |
| |
David Hinkle, MD, Ph.D.
University of Pittsburgh
Pittsburg, PA | The Potential Role of Antioxidant Systems in the Mechanism of DJ-1 Dependent Astrocytemediated Neuroprotection |
| |
Bradley Miller, MD, Ph.D.
University of Virginia
Charlottesville, VA | Distribution and Metabolic Consequences of Mitochondrial DNA Deletions in Substantia Nigra and Cultured Cells |
| |
|
Roger C. Duvoisin, MD, Research Grant |
Andrei Alexandrescu, Ph.D.
University of Connecticut
Storrs, CT | Stability and Solvent Accessibility of Alpha-Synuclein Fibrils by NMR Hydrogen Exchange |
| |
Marc Tatar, Ph.D.
Brown University
Providence, RI | Assessing the Pathogenic and Molecular Consequences of FOXO Regulation by Parkin |
| |
Jeffrey Stock, Ph.D.
Princeton University
Princeton, NJ | Protein Phosphatase 2A Methylation as a Therapeutic Target for Parkinson’s Disease |
| |
|
Research Grants |
Matthew Goldberg, Ph.D.
UT Southwestern Medical Center
Dallas, TX | Parkin, DJ-1 and Glutathione Peroxidase-Deficient Mouse Models of PD |
| |
Jean Rochet, Ph.D.
Purdue University
West Lafayette, IN | Role of ATP13A2 (PARK9) Dysfunction in Parkinson’s Disease |
| |
Hardy Rideout, Ph.D.
Columbia University
New York, NY | Modification of LRRK2 Oligomerization and Neurodegeneration by 14-3-3 |
| |
Arnulfo Quesada, Ph.D.
Brentwood Biomedical Research Institute
Los Angeles, CA | A Promising New Protective Factor for Parkinson’s Disease |
| |
Anthony Nicholas, MD, Ph.D.
University of Alabama
Birmingham, AL | Gene Analysis of Histone Deacetylation in Levodopa-Induced Dyskinesia and Priming |
| |
Darren Moore, Ph.D.
Johns Hopkins University
Baltimore, MD | Dopamine Neuron-Specific Accumulation of Mitochondrial DNA Mutations in Mice |
| |
Subhojit Roy, Ph.D.
University of California
Jolla, CA | Effects of Alpha-Synuclein on Fast and Slow Axonal Transport |
| |
Steven Johnson, MD, Ph.D.
Portland VA Research
Portland, OR | Redox Regulation of NMDA Currents in Midbrain Dopamine Neurons |
| |
Jian Feng, Ph.D.
State University of New York
Buffalo, NY | Generating Patient –Specific Induced Pluripotent Stem Cells to Study Parkinson’s Disease |
| |
Wei Ming Duan, MD, Ph.D.
Louisiana State University
Shreveport, LA | Generation of Dopaminergic Neurons from Endogenous Stem Cells in the Brain of a Mouse Model of Parkinson’s Disease |
| |
Paul Davenport, Ph.D.
University of Florida
Gainesville, FL | Central Neural Gating of Pharyngeal Mechanically Elicited Cortical Evoked Potentials (CEP): An Evaluation of Swallow Neural Integration in Parkinson’s Disease (PD) |
| |
Shankar Chinta, Ph.D.
Buck Institute for Age Research
Novato, CA | Potential Neuroprotective Role of Resveratrol in Parkinson’s Disease Mouse Models |
| |
Shu Chen, Ph.D.
Case Western Reserve University
Cleveland, OH | Transgenic C. Elegans Model of LRRK2-Linked Parkinson Disease |
| |
Linan Chen, MD, Ph.D.
University of Chicago
Chicago, IL | Transgenic Overexpression Selectively in Dopamine Neurons via Controlled Genetic Amplification |
| |
Savio Chan, Ph.D.
Northwestern University
Chicago, IL | Sriatopallidal GABAergic Signaling in Mouse Models of Parkinson’s Disease |
| |
Ippolita Castelvetri, Ph.D.
Massachusetts General Hospital
Charlestown, MA | Biological Basis for Diferential Susceptibility to Alpha-Synuclein Pathology in the Male and Femal Human Brain |
| |
Hans Bueler, Ph.D.
University of Kentucky
Lexington, KY | Identification of PINK1 Substrates Using Conditional PINK1 Knockout Cells and Quantitative Phosphoproteomics |
| |
Shubhik Kumar, Ph.D.
Lake Forest College
Lake Forest, IL | A Study of Autophagic Regulation of Alpha-Synuclein Toxicity in Yeast |
| |
Jianhui Zhu, Ph.D.
University of Pittsburgh
Pittsburgh, PA | ATP13A2 and Autolysosomal Pathology in Parkinson’s Disease |
| |
Derek Siebruth, Ph.D.
University of Southern California
Los Angeles, CA | Large Scale Analysis of Synaptic Architecture in Alphasynuclein Expressing Neurons |
| |
Gaofeng Wang, Ph.D.
University of Miami
Coral Gables, FL | The Role of miRNA in Olfactory Deficit of Parkinson’s Disease |
| |
Andrew West, Ph.D.
University of Alabama
Birmingham, AL | Development of Cell Based Kinase Assays for LRRK2 |
| |
Gerardo Morfini, Ph.D.
University of Illinois
Chicago, IL | Molecular Mechanisms Underlying MPP+ Induced Activation of Cytoplamic Dynein-Based Vesicle Transport |
| |
Fu-Ming Zhou, MD, Ph.D.
University of Tennessee
Memphis, TN | An Ultra Short Dopamine Pathway: Part II. Signaling Mechanisms |
| |
Xiongwei Zhu, Ph.D.
Case Western Reserve University
Cleveland, OH | Role of Impaired Mitochondrial Dynamics in Mutant LRRK2 Induced Toxicity |
| |
Harrison Walker, MD
University of Alabama
Birmingham, AL | Bilateral Clinical and Neurophysiological Effects of Unilateral STN DBS in PD |
| |
| |
| |
Kala Venkiteswaran, Ph.D.
Penn State Hershey College of Medicine
Hershey, PA | Transplantation of Transdifferentiated Dopaminergic Neurons Derived from Human Retinal Pigment Epithelial Cells |
| |
Enrique Torre, Ph.D.
Emory University
Atlanta, GA | Significance of mRNA Transport and Translation within the Dopaminergic Axon |
| |
Shaji Theodore, Ph.D.
University of Alabama
Birmingham, AL | Inhibiting Nuclear Factor Kappa B Signaling and Microglial Activation in a Mouse Model of Parkinson’s Disease |
| |
Wanli Smith, MD, Ph.D.
Johns Hopkins University School of Med.
Baltimore, MD | Autophagy and LRRK2-Linked Parkinsonism |
| |
Kui Xu, MD, Ph.D.
Massachusetts General Hospital
Boston, MA | Neuroprotection by Urate in Cellular Models of Parkinson’ s Disease |
| |
|
Post-Doctoral Fellowships |
Gizem Donmez, Ph.D.
Massachusetts Institute of Technology
Cambridge, MA | Analysis of the Role of SIRT2 Protein in Parkinson’s Disease |
| |
Nanyan Zhang, Ph.D.
University of Colorado
Aurora, CO | Delineating Protein Coaggregation during Lewy Body Formation |
| |
Yulan Xiong, Ph.D.
Johns Hopkins University
Baltimore, MD | Modeling LRRK2-Induced Toxicity in Yeast |
| |
Ravindar Thomas, Ph.D.
University of Virginia
Charlottesville, VA | Development of Mitochondrial Gene Therapy for Parkinson’s Disease |
| |
Jason Cannon, Ph.D.
University of Pittsburgh
Pittsburgh, PA | Genetic and Environmental Interactions in Parkinson’s Disease: Potential for New Therapeutic Pathways |
| |
William Caudle, Ph.D.
University of Washington
Seattle, WA | Proteomic Analysis of VMAT2 under Normal and Pathological Conditions |
| |
Robert Drolet, Ph.D.
University of Pittsburgh
Pittsburgh, PA | Gastrointestinal Dysfunction in the Rotenone Model of Parkinson’s Disease |
| |
Muralidhar Hedge, Ph.D.
Uiversity of Texas
Galveston, TX | Role of Transition Metals in Inhibiting Repair of Oxidized Bases in Genome: Relevance to Parkinson’s Disease |
| |
William Lin, Ph.D.
University of Chicago
Chicago, IL | Mechanism and Function of Cytosolic PINK1 |
| |
Zhihui Sun, Ph.D.
University of Pennsylvania
Philadelphia, PA | Investigating Synuclein Gene FunctionIn Zebrafish |
| |
Stephen Crimmins, Ph.D.
University of Alabama
Birmingham, AL | Reduction of Alpha-Synuclein and Neuroprotection Against its Toxicity by Enhancing Proteasome Activities |
| |
Yeun Su Choo, Ph.D.
Burnham Institute for Medical Research
La Jolla, CA | Regulation of Parkin by Neddylation |
| |
Daniel Tardiff, Ph.D.
Whitehead Institute for Biomedical Res.
Cambridge, MA | Mitochondrial Proteomics of a Yeast Parkinson’s Disease Model |
| |
|
Medical Students Summer Fellowships |
Ephraim Church | University of Pennsylvania
Philadelphia, PA |
| |
Neena Marupudi | Penn State College of Medicine
Hershey, PA |
| |
Omar Atassi | Johns Hopkins University
Baltimore, MD |
| |
Anthony Burrows | University of Massachusetts Med. School
Worcester, MA |
| |
Jennifer Kosty | University of Pennsylvania
Philadelphia, PA |
| |
Jennifer O’Malley | University of Cincinnati
Cincinnati, OH |
| |
|
Centers for Advanced Research |
The University of Chicago
Chicago, IL | Boston University School of Medicine
Marie St. Hilaire, MD
Boston, MA |
| |
Emory University School of Medicine
Mahlon DeLong, MD
Atlanta, GA | University of Virginia Medical Center
Frederick G. Wooten, MD
Charlottesville, VA |
| |
UCLA School of Medicine
Marie Francois Chessiet, MD, PhD
Los Angeles, CA | Washington University Medical Center
Joel Perlmutter, MD
St. Louis, MO |
| |
University of Pittsburgh
J. Timothy Greenamyre, MD, PhD
Pittsburgh, PA | |
| |
University of Alabama
David Standaet, MD
Birmingham, AL | Robert Wood Johnson Medical School
Jacob Sage, MD
New Brunswick, NJ |
| |